Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer
NCT ID: NCT04175444
Last Updated: 2023-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2020-06-15
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Several devices have been developed since the advent of the Octopus Perimeter and the Humphrey Field Analyzer (HFA) in an effort to improve the early detection of glaucoma. Several of these visual field test variants are implemented using laptops, iPads, and virtual reality headsets. These modalities bring portability but lack fixation methods, environmental control, and hardware standardization. These deficiencies may limit their wide usage.
The main goal of this study is to develop an initial pediatric reference database of a novel visual field test ecosystem that takes advantage of a Head Mounted Device (HMD).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
NCT05150197
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics
NCT02157025
Test-Retest Reliability of oVEMP's Across Different Electrode Montages
NCT03251586
Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic
NCT04391166
Vestibular Infant Screening - Rehabilitation
NCT06177132
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Participants that qualify for the study will be invited to a clinical site of the Vanderbilt Eye Institute or equivalent testing space and best corrected visual acuity will be checked with standard Snellen Acuity chart.
* Once vision is confirmed to meet study requirements, the child will be instructed on how to use the headset.
* The test will be generated and participant will complete various testing strategies including suprathreshold, full threshold and individual point testing and possibly other strategies for frequency of seeing curves.
* Patient with pathology may be confirmed with formal standard of care visual field testing
* Short survey will be administered to inquire on ease of device use
* Data will be submitted for analysis
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Subjects
This is a study of normal subjects to establish a normative database.
VisuALL Field Analyzer
Each participant will conduct a visual field test with the visuaALL headset.
Humphrey Field Analyzer
Each participant will conduct a standard of care Humphrey Visual Field.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VisuALL Field Analyzer
Each participant will conduct a visual field test with the visuaALL headset.
Humphrey Field Analyzer
Each participant will conduct a standard of care Humphrey Visual Field.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected visual acuity (BVCA) 20/25 or better in each eye
Exclusion Criteria
* Intraocular surgery in the study eye
* History of systemic condition known to affect visual function.
* History of medication known to affect visual function.
8 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sylvia L. Groth, MD
Assistant Professor of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvia Groth, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000000001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.